Clinical Trials Sponsored by Oasis Pharmaceuticals, LLC

Total 627 results

Cubist Pharmaceuticals LLC

Terminated

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Complicated Skin or Skin Structure Infection

United States
Cubist Pharmaceuticals LLC

Completed

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

Complicated Intra-abdominal Infection

United States, Argentina, Israel, Bulgaria, Serbia, Korea, Republic of, Estonia, Chile, Hungary, Lithuania, Latvia, Croatia, Moldova, Republic of, Poland, Germany
Cubist Pharmaceuticals LLC

Terminated

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

Ventilator-Associated Pneumonia (VAP)

United States, Australia, New Zealand
Cubist Pharmaceuticals LLC

Terminated

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Opioid-Induced Constipation
Cubist Pharmaceuticals LLC

Terminated

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Opioid-Induced Constipation
Cubist Pharmaceuticals LLC

Completed

Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Constipation
Edgemont Pharmaceuticals, LLC

Completed

EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder (GAD)

United States
Cubist Pharmaceuticals LLC

Completed

Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Opioid Induced Constipation
Cubist Pharmaceuticals LLC

Completed

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Diarrhea | Clostridium Difficile Infection

United States, Canada
Cubist Pharmaceuticals LLC

Completed

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

End-stage Renal Disease | Renal Failure Chronic Requiring Hemodialysis

United States
Cubist Pharmaceuticals LLC

Completed

Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

End-Stage Renal Disease
Cubist Pharmaceuticals LLC

Completed

Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

Cellulitis

United States
Iroko Pharmaceuticals, LLC

Completed

Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age

Pain, Postoperative

United States
Cubist Pharmaceuticals LLC

Terminated

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Gram-Positive Bacterial Infections
Optimer Pharmaceuticals LLC

Completed

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea | Clostridium Infections

United States, France, United Kingdom, Belgium, Spain, Canada, Germany, Italy, Sweden
Optimer Pharmaceuticals LLC

Completed

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea

United States
Hikma Pharmaceuticals LLC

Completed

Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan (CCMLJ)

Chronic Myeloid Leukemia, Chronic Phase

Jordan
Cubist Pharmaceuticals LLC

Completed

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Postoperative Ileus

United States
Cubist Pharmaceuticals LLC

Completed

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Marathon Pharmaceuticals, LLC

Withdrawn

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

Short Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut | Short Bowel

United States
Amneal Pharmaceuticals, LLC

Completed

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

Atrophic Vaginitis Due to Menopause

United States
Iroko Pharmaceuticals, LLC

Completed

Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

Osteoarthritis

United States
Ausio Pharmaceuticals, LLC

Completed

Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients

Menopause

United States, Australia
Iroko Pharmaceuticals, LLC

Completed

Study of Indomethacin Capsules to Treat Pain Following Bunionectomy

Other Acute Postoperative Pain

United States
Iroko Pharmaceuticals, LLC

Completed

Study of Diclofenac Capsules to Treat Pain Following Bunionectomy

Other Acute Postoperative Pain

United States
Iroko Pharmaceuticals, LLC

Completed

Study of Naproxen Capsules to Treat Dental Pain

Dental Pain

United States
Ausio Pharmaceuticals, LLC

Completed

Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers

Healthy

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Actinic Keratosis

United States, Canada
Graceway Pharmaceuticals, LLC

Completed

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

Actinic Keratoses
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Cognition Pharmaceuticals, LLC

Completed

A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis

Multiple Sclerosis | Cognition Disorders

United States
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
GTO Pharmaceutical, LLC

Terminated

Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment

Female Sexual Dysfunction | Vulvovaginal Atrophy | Vulvodynia | Dyspareunia | Vestibulodynia | Postmenopausal Symptoms | Arousal Disorders, Sexual | Genito-Pelvic Pain/Penetration Disorder | Female Sexual Arousal Disorder | Sexual Pain Disorders

United States
Advenchen Pharmaceuticals, LLC.

Recruiting

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

Small Cell Lung Cancer

United States
Timber Pharmceuticals LLC

Completed

A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis

Congenital Ichthyosis

United States, Australia
Amneal Pharmaceuticals, LLC
Oxford Pharmaceutical Resources, Inc.; Sristek Clinical Research; Biostudy Solutions...

Completed

Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo

Pain | Urinary Tract Infections

United States
EMET Pharmaceuticals, LLC
Eagle Pharmaceuticals, Inc.

Completed

A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis

Mild to Moderate Ulcerative Colitis
60 Degrees Pharmaceuticals LLC

Completed

Long-Term Safety Study of Tafenoquine

Healthy Volunteers

Australia, United States
Castle Creek Pharmaceuticals, LLC

Terminated

Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)

Epidermolysis Bullosa Simplex

United States, Israel, Australia, Austria, France, Germany, Netherlands, United Kingdom
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

Constipation | Bowel Dysfunction

United States, Netherlands, Spain, Taiwan, Peru, Philippines, France, United Kingdom, Canada, Czechia, Finland, Korea, Republic of, Hong Kong, Pakistan, Thailand, Italy, Argentina, Poland, Hungary, Germany, Russian Federation, South... and more
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

Ileus

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Terminated

Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid

Cancer | Constipation
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Constipation | Bowel Dysfunction

United States, Australia, Canada, Hungary, Netherlands, Spain, Sweden, France, New Zealand, Norway, South Africa, Switzerland
Cubist Pharmaceuticals LLC
Pfizer

Completed

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
High Point Pharmaceuticals, LLC.

Terminated

Safety Study of HPP593 in Subjects During and After Limb Immobilization

Muscle Atrophy | Hypodynamia

United States
AmDerma
AmDerma Pharmaceuticals, LLC

Completed

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Tinea Pedis | Athlete's Foot

United States
60 Degrees Pharmaceuticals LLC

Not yet recruiting

Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

Babesiosis

Clinical Trials Sponsored by Oasis Pharmaceuticals, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations